Acute paralysis following recreational MDMA (Ecstasy) use

被引：5

作者：

Goldstein, Lee H.

Mordish, Yair

Abu-Kishak, Ibrahim

Toledano, Michal

Berkovitch, Matitiahu ^{[1
]}

机构：

[1] Tel Aviv Univ, Clin Pharmacol & Toxicol Unit, Assaf Harofeh Med Ctr, Sackler Sch Med, IL-70300 Zerifin, Israel

[2] Tel Aviv Univ, Div Pediat, Assaf Harofeh Med Ctr, Sackler Sch Med, IL-70300 Zerifin, Israel

[3] Tel Aviv Univ, Pediat Intens Care Unit, Assaf Harofeh Med Ctr, Sackler Sch Med, IL-70300 Zerifin, Israel

[4] Assaf Harofeh Med Ctr, Dept Pharm, IL-70300 Zerifin, Israel

来源：

CLINICAL TOXICOLOGY | 2006年 / 44卷 / 03期

关键词：

ecstasy; methylenedioxymethamphetamine; spinal cord; quadriplegia; respiratory insufficiency; adolescent; renal failure;

D O I：

10.1080/15563650600584600

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

Methylenedioxymethamphetamine (MDMA), commonly known as Ecstasy, is a hallucinogenic compound structurally related to amphetamine. Ecstasy's severe neurological toxicity includes seizures, subarachnoidal hemorrhage, cerebral infarction, intracranial bleeding and cerebral venous thrombosis. We describe the first case of spinal cord damage presenting as acute quadriplegia and respiratory insufficiency in a healthy adolescent following Ecstasy recreational usage.

引用

页码：339 / 341

页数：3

共 50 条

[21] Methylenedioxymethamphetamine (MDMA, "Ecstasy")
Shannon, M
PEDIATRIC EMERGENCY CARE, 2000, 16 (05) : 377 - 380
[22] Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Gouzoulis-Mayfrank, E
Daumann, J
Tuchtenhagen, F
Pelz, S
Becker, S
Kunert, HJ
Fimm, B
Sass, H
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (06) : 719 - 725
[23] Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
Parrott, AC
JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (01) : 71 - 83
[24] MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users
Parrott, Andrew C.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2013, 37 (08) : 1466 - 1484
[25] Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA; ''Ecstasy'')
Cohen, RS
Cocores, J
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (04) : 727 - 734
[26] A review of the acute subjective effects of MDMA/ecstasy
Baylen, Chelsea A.
Rosenberg, Harold
ADDICTION, 2006, 101 (07) : 933 - 947
[27] Acute ascending aortic dissection after MDMA/ecstasy use: A case report
Kanahara, Satoko
El-Refai, Mostafa
Lakkis, Nasser
Tabbaa, Rashed
HELLENIC JOURNAL OF CARDIOLOGY, 2016, 57 (05) : 351 - 354
[28] Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: A WWW study
Scholey, AB
Parrott, AC
Buchanan, T
Heffernan, TM
Ling, J
Rodgers, J
ADDICTIVE BEHAVIORS, 2004, 29 (04) : 743 - 752
[29] The current aspects of the use of ecstasy/MDMA in France
Spadari, Michel
Batisse, Anne
Guerlais, Marylene
Boucher, Alexandra
Daveluy, Amelie
Le Boisselier, Reynald
Gibaja, Valerie
Eiden, Celine
Lepelley, Marion
Roussin, Anne
Deheul, Sylvie
Frauger, Elisabeth
Debruyne, Daniele
THERAPIE, 2016, 71 (06): : 553 - 562
[30] Chronic MDMA (ecstasy) use, cognition and mood
McCardle, K
Luebbers, S
Carter, JD
Croft, RJ
Stough, C
PSYCHOPHARMACOLOGY, 2004, 173 (3-4) : 434 - 439

← 1 2 3 4 5 →